Loading...
XNAS:RVPH
Reviva Pharmaceuticals shares are trading lower after lacking new analyst ratings or financial updates ahead of the company's key opinion leader webinar.
Reviva Pharmaceuticals shares are trading lower after the company announced a $9 million public offering, diluting existing shareholders.
Reviva Pharmaceuticals shares are trading higher after reporting successful clinical trials for brilaroxazine and plans for a New Drug Application submission in 2026 for schizophrenia treatment.
Reviva Pharmaceuticals shares are trading lower after the company announced the pricing of a $10 million public offering, increasing the supply of its stock.
Reviva Pharmaceuticals shares are trading lower after the company announced a proposed public offering of common stock and warrants.